IMRX
#3229
Immuneering Corporation - Class A Common Stock
5.2 1 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.97%
Monthly Change
+24.34%
6 month change
+12.77%
Year Change
+28.33%
Previous Close
5.1 6
Open
5.2 1
Low
5.2 1
High
5.2 1
Volume
73
Financials
- Market Capitalization 337.07 M
- Employee 55
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3217 |  HELP Cybin Inc. - Common Stock | 6.68 USD | -0.30% | +13.03% | +56.81% | -25.53% | 344.90 M USD | ||
| 3225 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.77 USD | +3.25% | 0.00% | +26.86% | +253.33% | 339.56 M USD | ||
| 3230 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.57 USD | -0.34% | -0.27% | +15.00% | -4.58% | 336.55 M USD | ||
| 3232 |  PALI Palisade Bio, Inc. - Common Stock | 1.93 USD | +2.12% | -5.85% | +14.88% | +13.53% | 335.01 M USD |
Frequently asked questions about Immuneering Corporation - Class A Common Stock
What is the Immuneering Corporation - Class A Common Stock stock price today?
The current price of Immuneering Corporation - Class A Common Stock (IMRX) is 5.21. Over the past 24 hours, the stock has changed by +0.97%. Follow the IMRX chart for real-time price dynamics.
What is the stock ticker of Immuneering Corporation - Class A Common Stock?
Immuneering Corporation - Class A Common Stock trades under the ticker IMRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immuneering Corporation - Class A Common Stock stock going up?
IMRX has changed by +0.97% over the last week, +24.34% over the last month, and +28.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Immuneering Corporation - Class A Common Stock net income for the last quarter?
Immuneering Corporation - Class A Common Stock reported net income of -13.46 M for the last quarter. The previous quarter showed -11.58 M, which means net income changed by -16.24%.
How many employees does Immuneering Corporation - Class A Common Stock have?
As of the latest available data, Immuneering Corporation - Class A Common Stock has 55 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Immuneering Corporation - Class A Common Stock stock?
You can buy Immuneering Corporation - Class A Common Stock (IMRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immuneering Corporation - Class A Common Stock stock?
Investing in Immuneering Corporation - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMRX chart and related analysis on metatrader.com as part of your research.